Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 6 studies | 26% ± 13% | |
squamous epithelial cell | 3 studies | 38% ± 16% | |
dendritic cell | 3 studies | 21% ± 3% |
Insufficient scRNA-seq data for expression of TICAM1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2516.09 | 1445 / 1445 | 100% | 68.28 | 183 / 183 |
intestine | 100% | 1448.55 | 966 / 966 | 100% | 50.01 | 526 / 527 |
skin | 100% | 2205.16 | 1809 / 1809 | 100% | 36.02 | 470 / 472 |
stomach | 100% | 1487.65 | 359 / 359 | 99% | 49.32 | 284 / 286 |
breast | 100% | 1486.63 | 459 / 459 | 99% | 37.52 | 1106 / 1118 |
uterus | 100% | 1197.36 | 170 / 170 | 99% | 45.98 | 454 / 459 |
prostate | 100% | 1243.27 | 245 / 245 | 99% | 31.97 | 496 / 502 |
lung | 100% | 2054.12 | 578 / 578 | 99% | 38.77 | 1139 / 1155 |
thymus | 100% | 1127.56 | 651 / 653 | 99% | 27.91 | 597 / 605 |
liver | 100% | 1296.41 | 226 / 226 | 98% | 34.82 | 399 / 406 |
pancreas | 98% | 734.94 | 323 / 328 | 99% | 56.21 | 177 / 178 |
bladder | 100% | 1274.05 | 21 / 21 | 98% | 39.01 | 493 / 504 |
ovary | 100% | 888.36 | 180 / 180 | 98% | 30.65 | 420 / 430 |
kidney | 100% | 1535.20 | 89 / 89 | 98% | 43.47 | 879 / 901 |
brain | 88% | 601.85 | 2329 / 2642 | 99% | 22.56 | 696 / 705 |
adrenal gland | 100% | 756.75 | 257 / 258 | 87% | 17.29 | 200 / 230 |
eye | 0% | 0 | 0 / 0 | 100% | 30.78 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 47.03 | 29 / 29 |
muscle | 100% | 1422.96 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1485.87 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 57.31 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 15.77 | 1 / 1 |
adipose | 100% | 1573.19 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1681.87 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 752.74 | 846 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 1678.78 | 912 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0035666 | Biological process | TRIF-dependent toll-like receptor signaling pathway |
GO_0031663 | Biological process | lipopolysaccharide-mediated signaling pathway |
GO_0002224 | Biological process | toll-like receptor signaling pathway |
GO_0032722 | Biological process | positive regulation of chemokine production |
GO_0097190 | Biological process | apoptotic signaling pathway |
GO_0032728 | Biological process | positive regulation of interferon-beta production |
GO_0006954 | Biological process | inflammatory response |
GO_0045087 | Biological process | innate immune response |
GO_0002735 | Biological process | positive regulation of myeloid dendritic cell cytokine production |
GO_0034138 | Biological process | toll-like receptor 3 signaling pathway |
GO_0043330 | Biological process | response to exogenous dsRNA |
GO_0051607 | Biological process | defense response to virus |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0032481 | Biological process | positive regulation of type I interferon production |
GO_1900017 | Biological process | positive regulation of cytokine production involved in inflammatory response |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0010508 | Biological process | positive regulation of autophagy |
GO_0006809 | Biological process | nitric oxide biosynthetic process |
GO_0030890 | Biological process | positive regulation of B cell proliferation |
GO_0032816 | Biological process | positive regulation of natural killer cell activation |
GO_0045429 | Biological process | positive regulation of nitric oxide biosynthetic process |
GO_0034142 | Biological process | toll-like receptor 4 signaling pathway |
GO_0060907 | Biological process | positive regulation of macrophage cytokine production |
GO_0043254 | Biological process | regulation of protein-containing complex assembly |
GO_0002281 | Biological process | macrophage activation involved in immune response |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0042100 | Biological process | B cell proliferation |
GO_0031398 | Biological process | positive regulation of protein ubiquitination |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0140052 | Biological process | cellular response to oxidised low-density lipoprotein particle stimulus |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0097342 | Cellular component | ripoptosome |
GO_0005739 | Cellular component | mitochondrion |
GO_0005769 | Cellular component | early endosome |
GO_0005829 | Cellular component | cytosol |
GO_0005776 | Cellular component | autophagosome |
GO_0010008 | Cellular component | endosome membrane |
GO_0005768 | Cellular component | endosome |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0035591 | Molecular function | signaling adaptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | TICAM1 |
Protein name | TIR domain-containing adapter molecule 1 (TICAM-1) (Proline-rich, vinculin and TIR domain-containing protein B) (Putative NF-kappa-B-activating protein 502H) (Toll-interleukin-1 receptor domain-containing adapter protein inducing interferon beta) (MyD88-3) (TIR domain-containing adapter protein inducing IFN-beta) |
Synonyms | TRIF PRVTIRB |
Description | FUNCTION: Involved in innate immunity against invading pathogens. Adapter used by TLR3, TLR4 (through TICAM2) and TLR5 to mediate NF-kappa-B and interferon-regulatory factor (IRF) activation, and to induce apoptosis . Ligand binding to these receptors results in TRIF recruitment through its TIR domain . Distinct protein-interaction motifs allow recruitment of the effector proteins TBK1, TRAF6 and RIPK1, which in turn, lead to the activation of transcription factors IRF3 and IRF7, NF-kappa-B and FADD respectively . Phosphorylation by TBK1 on the pLxIS motif leads to recruitment and subsequent activation of the transcription factor IRF3 to induce expression of type I interferon and exert a potent immunity against invading pathogens . Component of a multi-helicase-TICAM1 complex that acts as a cytoplasmic sensor of viral double-stranded RNA (dsRNA) and plays a role in the activation of a cascade of antiviral responses including the induction of pro-inflammatory cytokines (By similarity). . |
Accessions | Q8IUC6 ENST00000248244.6 |